# Rayonier Inc: financial statements, quarterly

RYN · NYSE · CIK 52827 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ryn.md) · [Financials](/companies/ryn/financials.md) · [Filings](/companies/ryn/filings.md) · [Insiders](/companies/ryn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ryn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [209](/filings/0000052827-24-000188.md) | [201](/filings/0000052827-24-000204.md) | [198 d](/filings/0000052827-26-000036.md) | [113](/filings/0000052827-25-000101.md) | [99.3](/filings/0000052827-25-000164.md) | [124](/filings/0000052827-25-000187.md) | [650 d](/filings/0000052827-26-000036.md) | [82.6](/filings/0000052827-26-000078.md) | [106](/filings/0000052827-25-000164.md) | [177](/filings/0000052827-25-000187.md) | [117 d](/filings/0000052827-26-000036.md) | [277](/filings/0000052827-26-000078.md) |
| Cost of revenue | $m | [168](/filings/0000052827-24-000188.md) | [146](/filings/0000052827-24-000204.md) | [65.7 d](/filings/0000052827-26-000036.md) | [86.1](/filings/0000052827-25-000101.md) | [74.3](/filings/0000052827-25-000164.md) | [86.3](/filings/0000052827-25-000187.md) | [301 d](/filings/0000052827-26-000036.md) | [65.0](/filings/0000052827-26-000078.md) | [74.9](/filings/0000052827-25-000164.md) | [119](/filings/0000052827-25-000187.md) | [68.2 d](/filings/0000052827-26-000036.md) | [230](/filings/0000052827-26-000078.md) |
| Selling, general and administrative | $m | [19.0](/filings/0000052827-24-000188.md) | [18.9](/filings/0000052827-24-000204.md) | [20.1 d](/filings/0000052827-26-000036.md) | [19.0](/filings/0000052827-25-000101.md) | [20.6](/filings/0000052827-25-000164.md) | [18.3](/filings/0000052827-25-000187.md) | [16.6 d](/filings/0000052827-26-000036.md) | [16.7](/filings/0000052827-26-000078.md) | [16.9](/filings/0000052827-25-000164.md) | [17.0](/filings/0000052827-25-000187.md) | [16.1 d](/filings/0000052827-26-000036.md) | [21.7](/filings/0000052827-26-000078.md) |
| Operating income | $m | [20.1](/filings/0000052827-24-000188.md) | [35.4](/filings/0000052827-24-000204.md) | [119 d](/filings/0000052827-26-000036.md) | [8.6](/filings/0000052827-25-000101.md) | [4.5](/filings/0000052827-25-000164.md) | [18.8](/filings/0000052827-25-000187.md) | [332 d](/filings/0000052827-26-000036.md) | [0.1](/filings/0000052827-26-000078.md) | [14.5](/filings/0000052827-25-000164.md) | [41.7](/filings/0000052827-25-000187.md) | [27.0 d](/filings/0000052827-26-000036.md) | [(45.7)](/filings/0000052827-26-000078.md) |
| Interest expense | $m | [12.5](/filings/0000052827-23-000189.md) | [12.6](/filings/0000052827-23-000212.md) | [11.6 d](/filings/0000052827-24-000014.md) | [9.7](/filings/0000052827-24-000150.md) | [9.0](/filings/0000052827-25-000164.md) | [9.2](/filings/0000052827-25-000187.md) | [6.6 d](/filings/0000052827-26-000036.md) | [6.4](/filings/0000052827-26-000078.md) | [6.5](/filings/0000052827-25-000164.md) | [6.8](/filings/0000052827-25-000187.md) | [6.6 d](/filings/0000052827-26-000036.md) | [14.3](/filings/0000052827-26-000078.md) |
| Income tax | $m | [0.2](/filings/0000052827-24-000188.md) | [0.5](/filings/0000052827-24-000204.md) | [(1.5) d](/filings/0000052827-26-000036.md) | [(1.0)](/filings/0000052827-25-000101.md) | [0.0](/filings/0000052827-25-000164.md) | [0.0](/filings/0000052827-25-000187.md) | [(0.0) d](/filings/0000052827-26-000036.md) | [0.3](/filings/0000052827-26-000078.md) | [0.0](/filings/0000052827-25-000164.md) | [0.0](/filings/0000052827-25-000187.md) | [0.2 d](/filings/0000052827-26-000036.md) | [(39.4)](/filings/0000052827-26-000078.md) |
| Net income | $m | [19.0](/filings/0000052827-24-000188.md) | [19.2](/filings/0000052827-24-000204.md) | [127 d](/filings/0000052827-26-000036.md) | [1.4](/filings/0000052827-25-000101.md) | [1.9](/filings/0000052827-25-000164.md) | [28.8](/filings/0000052827-25-000187.md) | [327 d](/filings/0000052827-26-000036.md) | [(3.4)](/filings/0000052827-26-000078.md) | [409](/filings/0000052827-25-000164.md) | [43.2](/filings/0000052827-25-000187.md) | [25.9 d](/filings/0000052827-26-000036.md) | [(12.4)](/filings/0000052827-26-000078.md) |
| Diluted EPS | $ per share | [0.13](/filings/0000052827-24-000188.md) | [0.13](/filings/0000052827-24-000204.md) | not reported | [0.01](/filings/0000052827-25-000101.md) | [0.01](/filings/0000052827-25-000164.md) | [0.19](/filings/0000052827-25-000187.md) | not reported | [(0.02)](/filings/0000052827-26-000078.md) | [2.63](/filings/0000052827-25-000164.md) | [0.28](/filings/0000052827-25-000187.md) | not reported | [(0.05)](/filings/0000052827-26-000078.md) |
| Basic EPS | $ per share | [0.13](/filings/0000052827-24-000188.md) | [0.13](/filings/0000052827-24-000204.md) | not reported | [0.01](/filings/0000052827-25-000101.md) | [0.01](/filings/0000052827-25-000164.md) | [0.19](/filings/0000052827-25-000187.md) | not reported | [(0.02)](/filings/0000052827-26-000078.md) | [2.63](/filings/0000052827-25-000164.md) | [0.28](/filings/0000052827-25-000187.md) | not reported | [(0.05)](/filings/0000052827-26-000078.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [88.4](/filings/0000052827-24-000188.md) | [108](/filings/0000052827-24-000204.md) | [208](/filings/0000052827-25-000018.md) | [142](/filings/0000052827-25-000101.md) | [120](/filings/0000052827-25-000164.md) | [51.9](/filings/0000052827-25-000187.md) | [303](/filings/0000052827-26-000036.md) | [216](/filings/0000052827-26-000078.md) | [892](/filings/0000052827-25-000164.md) | [920](/filings/0000052827-25-000187.md) | [843](/filings/0000052827-26-000078.md) | [682](/filings/0000052827-26-000078.md) |
| Current assets | $m | [197](/filings/0000052827-23-000189.md) | [223](/filings/0000052827-23-000212.md) | [317](/filings/0000052827-25-000018.md) | [280](/filings/0000052827-24-000150.md) | [230](/filings/0000052827-24-000188.md) | [277](/filings/0000052827-24-000204.md) | [437](/filings/0000052827-26-000036.md) | [767](/filings/0000052827-25-000101.md) | [960](/filings/0000052827-25-000164.md) | [973](/filings/0000052827-25-000187.md) | [884](/filings/0000052827-26-000078.md) | [896](/filings/0000052827-26-000078.md) |
| Total assets | $m | [3,722](/filings/0000052827-23-000189.md) | [3,708](/filings/0000052827-23-000212.md) | [3,648](/filings/0000052827-25-000018.md) | [3,570](/filings/0000052827-24-000150.md) | [3,539](/filings/0000052827-24-000188.md) | [3,479](/filings/0000052827-24-000204.md) | [3,474](/filings/0000052827-26-000036.md) | [3,351](/filings/0000052827-25-000101.md) | [3,514](/filings/0000052827-25-000164.md) | [3,492](/filings/0000052827-25-000187.md) | [3,405](/filings/0000052827-26-000078.md) | [7,745](/filings/0000052827-26-000078.md) |
| Current liabilities | $m | [103](/filings/0000052827-23-000189.md) | [111](/filings/0000052827-23-000212.md) | [140](/filings/0000052827-25-000018.md) | [114](/filings/0000052827-24-000150.md) | [116](/filings/0000052827-24-000188.md) | [139](/filings/0000052827-24-000204.md) | [389](/filings/0000052827-26-000036.md) | [283](/filings/0000052827-25-000101.md) | [274](/filings/0000052827-25-000164.md) | [283](/filings/0000052827-25-000187.md) | [271](/filings/0000052827-26-000078.md) | [354](/filings/0000052827-26-000078.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [1,512](/filings/0000052827-23-000189.md) | [1,511](/filings/0000052827-23-000212.md) | [1,366](/filings/0000052827-25-000018.md) | [1,362](/filings/0000052827-24-000150.md) | [1,364](/filings/0000052827-24-000188.md) | [1,285](/filings/0000052827-24-000204.md) | [1,044](/filings/0000052827-26-000036.md) | [1,045](/filings/0000052827-25-000101.md) | [845](/filings/0000052827-25-000164.md) | [845](/filings/0000052827-25-000187.md) | [845](/filings/0000052827-26-000078.md) | [1,855](/filings/0000052827-26-000078.md) |
| Current portion of debt | $m | not reported | not reported | [0.0](/filings/0000052827-25-000018.md) | not reported | not reported | [22.0](/filings/0000052827-24-000204.md) | [0.0](/filings/0000052827-26-000036.md) | not reported | [200](/filings/0000052827-25-000164.md) | [200](/filings/0000052827-25-000187.md) | [200](/filings/0000052827-26-000078.md) | [200](/filings/0000052827-26-000078.md) |
| Shareholders' equity | $m | [1,825](/filings/0000052827-23-000189.md) | [1,816](/filings/0000052827-23-000212.md) | [1,861](/filings/0000052827-25-000018.md) | [1,831](/filings/0000052827-24-000150.md) | [1,807](/filings/0000052827-24-000188.md) | [1,787](/filings/0000052827-24-000204.md) | [1,769](/filings/0000052827-26-000036.md) | [1,915](/filings/0000052827-25-000101.md) | [2,302](/filings/0000052827-25-000164.md) | [2,279](/filings/0000052827-25-000187.md) | [2,210](/filings/0000052827-26-000078.md) | [5,329](/filings/0000052827-26-000078.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.4 d](/filings/0000052827-24-000188.md) | [82.6 d](/filings/0000052827-24-000204.md) | [89.4 d](/filings/0000052827-26-000036.md) | [52.3](/filings/0000052827-25-000101.md) | [55.3 d](/filings/0000052827-25-000164.md) | [66.2 d](/filings/0000052827-25-000187.md) | [87.8 d](/filings/0000052827-26-000036.md) | [27.7](/filings/0000052827-26-000078.md) | [61.0 d](/filings/0000052827-25-000164.md) | [116 d](/filings/0000052827-25-000187.md) | [51.8 d](/filings/0000052827-26-000036.md) | [34.6](/filings/0000052827-26-000078.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [24.0](/filings/0000052827-25-000187.md) | [39.6 d](/filings/0000052827-25-000018.md) | not reported | not reported | [16.3](/filings/0000052827-25-000187.md) | not reported | not reported |
| Dividends paid | $m | [43.0 d](/filings/0000052827-24-000188.md) | [42.4 d](/filings/0000052827-24-000204.md) | [42.4 d](/filings/0000052827-26-000036.md) | [72.3](/filings/0000052827-25-000101.md) | [43.2 d](/filings/0000052827-25-000164.md) | [42.6 d](/filings/0000052827-25-000187.md) | [42.5 d](/filings/0000052827-26-000036.md) | [110](/filings/0000052827-26-000078.md) | [42.8 d](/filings/0000052827-25-000164.md) | [42.1 d](/filings/0000052827-25-000187.md) | [96.7 d](/filings/0000052827-26-000036.md) | [81.1](/filings/0000052827-26-000078.md) |
| Share repurchases | $m | [4.1 d](/filings/0000052827-24-000188.md) | [0.0 d](/filings/0000052827-24-000204.md) | [0.0 d](/filings/0000052827-26-000036.md) | [0.0](/filings/0000052827-25-000101.md) | [4.1 d](/filings/0000052827-25-000164.md) | [0.0 d](/filings/0000052827-25-000187.md) | [0.0 d](/filings/0000052827-26-000036.md) | [0.0](/filings/0000052827-26-000078.md) | [2.6 d](/filings/0000052827-25-000164.md) | [0.0 d](/filings/0000052827-25-000187.md) | [0.2 d](/filings/0000052827-26-000036.md) | [1.0](/filings/0000052827-26-000078.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0000052827-23-000189.md) | [150](/filings/0000052827-23-000212.md) | [151](/filings/0000052827-24-000150.md) | [151](/filings/0000052827-24-000188.md) | [151](/filings/0000052827-24-000204.md) | [149](/filings/0000052827-25-000101.md) | [149](/filings/0000052827-25-000164.md) | [151](/filings/0000052827-25-000187.md) | [154](/filings/0000052827-26-000078.md) | [158](/filings/0000052827-25-000164.md) | [156](/filings/0000052827-25-000187.md) | [256](/filings/0000052827-26-000078.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 300,747,223 at 2026-05-01, from the cover of the [10-Q filed 2026-05-08](/filings/0000052827-26-000078.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.